A new scale for grading ocular adverse events in oncology trials addresses ambiguities in CTCAE version 5 and includes dose modification recommendations. The scale, implemented in the I-SPY 2 trial, ...
An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will conduct a consensus study to identify how biological research at multiple scales can inform the development of ...
Any project, supported or not by a committee, that is currently being worked on or is considered active, and will have an end date. An ad hoc committee of the National Academies of Sciences, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback